Journal profile · Medicine-General Medicine
Fujita Medical Journal
ISSN 2189-7247 · eISSN 2189-7255 · Fujita Medical Society · Japan
Fujita Medical Journal: fully open access; APC charged, amount not published; median 102 days to acceptance (57 articles, last 24 months); indexed in Scopus.
Scope
Aims, scope and focus
Fujita Medical Journal is published by Fujita Medical Society. By OpenAlex counts of its recent articles, its largest topics are Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment and Breast Lesions and Carcinomas, together about 100% of its articles. Its main subfields are Hepatology, Epidemiology and Pathology and Forensic Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Fujita Medical Journal (FMJ) is an open-access, peer-reviewed journal committed to the rapid dissemination of innovative research in medicine, health sciences, and related fields. Our mission is to contribute to society by advancing medical knowledge and improving healthcare practices. FMJ aims to promote both basic and clinical medicine, welcoming a wide range of content, including original research articles, reviews, short reports, case reports, study protocols, cohort profiles, and letters to the editor. FMJ provides a platform for researchers, clinicians, and healthcare professionals to share groundbreaking findings, encourage collaboration, and support the ongoing advancement of medicine and health sciences. Published quarterly, FMJ ensures broad accessibility by making all articles freely available online, allowing for timely publication and facilitating the rapid exchange of knowledge and advancements across disciplines.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief Kazumitsu SUGIURAPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named Japan 26, United States 3, Mainland China 1, Taiwan, China 1, South Korea 1 (35 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hepatocellular Carcinoma Treatment and PrognosisMedicine33.3%
- Liver Disease Diagnosis and TreatmentMedicine33.3%
- Breast Lesions and CarcinomasMedicine33.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q3 | 384/669 | 42nd |
| General Health Professions | Q3 | 15/23 | 36th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.9LetPub ·
- SJR 2026-06
- 0.26LetPub ·
- SNIP 2026-06
- 0.34LetPub ·
- h-index
- 0OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
102 daysMedian, submission to acceptance · P25–P75 73 days – 140 days
- Acceptance to online
- median 122 days (57 articles)
- Submission to online
- median 222 days
- Sample
- 57 articles with submission and acceptance dates (76 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | JPY 120,000 | Yes | CC BY | |
| LetPub | JPY 120,000 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access
Open access under Creative Commons Attribution License Model summary
This is an open access article distributed under the teams of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Fujita Medical Society
- Country or region
- Japan
- Language
- English
- ISSN
- 2189-7247
- Electronic ISSN
- 2189-7255
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Fujita Medical Journal
How long does peer review take at Fujita Medical Journal?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 73–140 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Fujita Medical Journal based?
Of the 35 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are Japan (26), United States (3) and Mainland China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Fujita Medical Journal?
According to LetPub and DOAJ records, Fujita Medical Journal is indexed in Scopus and DOAJ.
Is Fujita Medical Journal open access, and what is the APC?
Fujita Medical Journal is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .